Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

J Dave, V Jagana, R Janostiak, M Bisserier - Journal of Translational …, 2023 - Springer
Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the
remodeling of pulmonary blood vessels. If left unaddressed, PAH can lead to right heart …

Association of respiratory infections and the impact of vaccinations on cardiovascular diseases

J Rademacher, M Therre, CA Hinze… - European Journal of …, 2024 - academic.oup.com
Influenza, pneumococcal, severe acute respiratory syndrome coronavirus 2, and respiratory
syncytial virus infections are important causes of high morbidity and mortality in the elderly …

Estimating the irreversible pressure drop across a stenosis by quantifying turbulence production using 4D Flow MRI

H Ha, J Lantz, M Ziegler, B Casas, M Karlsson… - Scientific reports, 2017 - nature.com
The pressure drop across a stenotic vessel is an important parameter in medicine, providing
a commonly used and intuitive metric for evaluating the severity of the stenosis. However …

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

RP Frantz, VV McLaughlin, S Sahay… - The Lancet …, 2024 - thelancet.com
Background Morbidity and mortality in pulmonary arterial hypertension (PAH) remain high.
Activation of platelet-derived growth factor receptor, colony stimulating factor 1 receptor, and …

[PDF][PDF] Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and …

P Bearzi, L Navarini, D Currado… - Clinical and …, 2024 - clinexprheumatol.org
Objective Bosentan is a dual endothelin receptor antagonist approved for the treatment of
SSc digital ulcers (DU) and pulmonary arterial hypertension (PAH). Systolic pulmonary …

Unraveling the Complex Relationship—Atrial Fibrillation and Pulmonary Hypertension

K Aggarwal, PS Valleru, FNU Anamika… - Current Cardiology …, 2024 - Springer
Abstract Purpose of Review In this article, we underscore the importance of identifying risk
factors and monitoring pulmonary hypertension patients for signs of arrhythmias, as this …

The association of right ventricular-pulmonary arterial coupling and pulmonary vascular resistance in adult patients with uncorrected atrial septal defect

CJ Cool, AF Khalid, N Sukmadi, MR Akbar… - BMC Cardiovascular …, 2024 - Springer
Background Atrial septal defects (ASD) are the most common type of adult congenital heart
disease (ACHD) associated with a high risk developing of pulmonary arterial hypertension …

Interstitial Lung Disease in Patients with Mixed Connective Tissue Disease: A Retrospective Study

X Shan, Y Ge - International Journal of General Medicine, 2024 - Taylor & Francis
Objective To investigate the clinical features, severity and prognosis of interstitial lung
disease (ILD) in patients with mixed connective tissue disease (MCTD). Methods We …

Improved Prognostic Performance of Right Atrial Pressure-Corrected Cardiac Power Output in Pulmonary Hypertension and Heart Failure with Preserved Ejection …

Y Wu, P Tian, L Liang, Y Chen, J Feng, B Huang… - Journal of …, 2024 - Springer
Cardiac power output (CPO) is a powerful predictor of adverse outcomes in heart failure
(HF). However, the original formula of CPO included the difference between mean arterial …

The safety and efficacy of gelatin sponge embolization for hemoptysis during balloon pulmonary angioplasty

S Higuchi, H Horinouchi, S Nakayama, T Aoki… - International Journal of …, 2024 - Elsevier
Background Vessel injury is a common complication during balloon pulmonary angioplasty
(BPA). For persistent hemoptysis, gelatin sponge embolization (GSE) is considered, but its …